Get started
Sartorius Stedim BiotechSartorius Stedim BiotechSartorius Stedim Biotech

Sartorius Stedim Biotech

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪19.43 B‬ USD
Dividend yield (indicated)
0.41%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
3.21 USD
Net income (FY)
‪311.95 M‬ USD
Revenue (FY)
‪3.49 B‬ USD
Shares float
‪25.65 M‬
Beta (1Y)
1.51

Employees


Employees (FY)
‪10.27 K‬
Change (1Y)
+364 +3.68%
Revenue / Employee (1Y)
‪339.54 K‬ USD
Net income / Employee (1Y)
‪30.39 K‬ USD

About Sartorius Stedim Biotech SA


Sector
Health Technology
Industry
Medical Specialties
CEO
René Fáber
Website
sartorius.com
Headquarters
Aubagne
Founded
1978
IPO date
Oct 20, 1994
Identifiers
2
ISIN FR0013154002
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.

Check out other big names from the same industry as SDMHF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VXUS
Vanguard Total International Stock ETF
Weight
0.02%
Market value
‪99.96 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.02%
Market value
‪64.50 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.02%
Market value
‪39.84 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.03%
Market value
‪20.35 M‬
USD
VGK
Vanguard FTSEEuropean ETF
Weight
0.05%
Market value
‪16.87 M‬
USD
VEU
Vanguard FTSE All World Ex US ETF
Weight
0.02%
Market value
‪14.96 M‬
USD
SCHF
Schwab International Equity ETF
Weight
0.02%
Market value
‪11.88 M‬
USD
EZU
iShares MSCI Eurozone ETF
Weight
0.08%
Market value
‪7.46 M‬
USD
MEUH
Amundi Core Stoxx Europe 600 -UCITS ETF HEDGED- Capitalisation
Weight
0.04%
Market value
‪7.38 M‬
USD
STXH
Amundi Index Solutions SICAV - Amundi Core Stoxx Europe 600 UCITS ETF Monthly Hedged to EUR - Dist- Distribution
Weight
0.04%
Market value
‪7.38 M‬
USD
MEUD
Amundi Core Stoxx Europe 600 -UCITS ETF Acc- Capitalisation
Weight
0.04%
Market value
‪7.38 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of SDMHF is 207.00 USD — it has decreased by −2.59% in the past 24 hours. Watch Sartorius Stedim Biotech stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sartorius Stedim Biotech stocks are traded under the ticker SDMHF.
SDMHF stock has fallen by −1.43% compared to the previous week, the month change is a −18.08% fall, over the last year Sartorius Stedim Biotech has showed a −5.26% decrease.
We've gathered analysts' opinions on Sartorius Stedim Biotech future price: according to them, SDMHF price has a max estimate of 327.08 USD and a min estimate of 249.77 USD. Watch SDMHF chart and read a more detailed Sartorius Stedim Biotech stock forecast: see what analysts think of Sartorius Stedim Biotech and suggest that you do with its stocks.
SDMHF reached its all-time high on Sep 10, 2021 with the price of 653.00 USD, and its all-time low was 3.40 USD and was reached on Feb 6, 2009. View more price dynamics on SDMHF chart.
See other stocks reaching their highest and lowest prices.
SDMHF stock is 3.37% volatile and has beta coefficient of 1.51. Track Sartorius Stedim Biotech stock price on the chart and check out the list of the most volatile stocks — is Sartorius Stedim Biotech there?
Today Sartorius Stedim Biotech has the market capitalization of ‪19.43 B‬, it has decreased by −6.39% over the last week.
Yes, you can track Sartorius Stedim Biotech financials in yearly and quarterly reports right on TradingView.
Sartorius Stedim Biotech is going to release the next earnings report on Apr 23, 2026. Keep track of upcoming events with our Earnings Calendar.
SDMHF earnings for the last quarter are 1.32 USD per share, whereas the estimation was 1.48 USD resulting in a −11.41% surprise. The estimated earnings for the next quarter are 1.49 USD per share. See more details about Sartorius Stedim Biotech earnings.
Sartorius Stedim Biotech revenue for the last quarter amounts to ‪906.96 M‬ USD, despite the estimated figure of ‪896.02 M‬ USD. In the next quarter, revenue is expected to reach ‪899.51 M‬ USD.
SDMHF net income for the last quarter is ‪55.08 M‬ USD, while the quarter before that showed ‪75.33 M‬ USD of net income which accounts for −26.88% change. Track more Sartorius Stedim Biotech financial stats to get the full picture.
Yes, SDMHF dividends are paid annually. The last dividend per share was 0.75 USD. As of today, Dividend Yield (TTM)% is 0.41%. Tracking Sartorius Stedim Biotech dividends might help you take more informed decisions.
Sartorius Stedim Biotech dividend yield was 0.33% in 2025, and payout ratio reached 25.27%. The year before the numbers were 0.37% and 38.14% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has ‪10.27 K‬ employees. See our rating of the largest employees — is Sartorius Stedim Biotech on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sartorius Stedim Biotech EBITDA is ‪1.69 B‬ USD, and current EBITDA margin is 28.43%. See more stats in Sartorius Stedim Biotech financial statements.
Like other stocks, SDMHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sartorius Stedim Biotech stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sartorius Stedim Biotech technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sartorius Stedim Biotech stock shows the strong sell signal. See more of Sartorius Stedim Biotech technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.